Drug Company Sales Reps In India Say Firms Overcharge At Will (India)
This article was originally published in PharmAsia News
Executive Summary
An organization representing a quarter of drug company sales representatives in India accuse the firms of arbitrarily increasing the prices of their products and getting away with it. The Federation of Medical and Sales Representatives' Associations of India made the accusations in notes to leading members of Parliament. The FMRAI said some companies have hiked their prices by as much as 100 times beyond the government-ordered price caps. Some essential or popular medicines have increased by 600 percent over the past nine years, said FMRAI's joint general secretary, who called the recent voluntary price reduction a "great hoax." Authorities have tried to recover some of the alleged overcharges, but drug companies have filed 75 court challenges against the efforts. (Click here for more ) "Medical Reps Accuse Drug Firms Of Overcharging" Business Standard (India) (12/10/07)